CAPIVASERTIB | CAPIVASERTIB : Inhibitor of AKT1, AKT2, AKT3
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (2 reviews)
Control Compounds

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
AKT1
  • IC50:3 nM
  • IC50:89 nM
AKT2
  • IC50:8 nM
    AKT3
    • IC50:8 nM
      Inhibitor
      up to 1 uM

      Selectivity

      In Vitro Selectivity Assessment
      Potency Assay Off-Target:
      AZD5363 was assayed against a larger enzyme panel of 75 kinases, of which 35 were also AGC family ki ...
      In Cell Selectivity Assessment
      Potency Assay Off-Target:
      The cellular IC50 against P70S6K was approximately 5 μM, as measured by inhibition of S6 phosphoryla ...

      Potency
      Cellular
      In Vitro

      AKT1

      Mode of Action: Inhibitor

      Structure-Activity-Relationship data available? Yes

      DOI Reference: 10.1021/jm301762v

      AKT2

      Mode of Action: Inhibitor

      Structure-Activity-Relationship data available? Yes

      DOI Reference: 10.1021/jm301762v

      AKT3

      Mode of Action: Inhibitor

      Structure-Activity-Relationship data available? Yes

      DOI Reference: 10.1021/jm301762v

      In Vivo Validations

      Mouse
      Dose:
      Route of delivery: Intravenous, Oral
      Plasma half life: 0.2 h
      Systemic clearance: 207 mL/min/Kg
      Bioavailability: 86%
      Volume of Distribution at Steady-State: 4.1 L/Kg

      DOI Reference: 10.1021/jm301762v

      Rat
      Dose:
      Route of delivery: Intravenous, Oral
      Plasma half life: 0.5 h
      Systemic clearance: 95 mL/min/Kg
      Bioavailability: 13%
      Volume of Distribution at Steady-State: 4.0 L/Kg

      DOI Reference: 10.1021/jm301762v

      Dog
      Dose:
      Route of delivery: Intravenous, Oral
      Plasma half life: 1.7 h
      Systemic clearance: 22 mL/min/Kg
      Bioavailability: 37%
      Volume of Distribution at Steady-State: 2.1 L/Kg

      DOI Reference: 10.1021/jm301762v

      Orthogonal Probes def

      BAY-1125976
      Borussertib

      Chemical Information

      Molecular Formula C21H25ClN6O2
      SMILEs NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1
      InChI InChI=1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1
      Molecular weight 428.17 Da
      AlogP 2.1489000000000003
      HBond acceptors 8
      HBond donors 5
      Atoms 55

      References

      Publications

      Cross References

      canSARChEMBLBindingDBPDB

      Vendors

      Note: This is not an exhaustive list and does not indicate endorsement by the portal.

      Expert Reviews


      (on 1 Dec 2023)
      Cellular Use Rating
      In Model Organisms
      The half-life is too short and the selectivity too poor to interrogate AKT1-3 in vivo with confidence.
      (on 23 Sept 2024)
      Cellular Use Rating
      In Model Organisms
      The compound is well characterized regarding on target data. However, better compounds for AKT exist (allosteric AKT inhibitors). AZD5363 offers a good alternative to allosteric AKT inhibitors, but does...
      Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria